87 results
Page 4 of 5
6-K
EX-10.1
f51vol3do
23 Sep 19
Anchiano Therapeutics Enters into An Exclusive Option To License Agreement for Novel Pan-RAS Inhibitor and PDE10/β-catenin Inhibitor Programs
5:29pm
20-F/A
vkze lktb6g6n9g
24 Apr 19
Annual report (foreign) (amended)
5:19pm
6-K
EX-4.1
w3lqr8 julki
14 Feb 19
Current report (foreign)
4:40pm
6-K
EX-1.1
fhrd6sg11ynwtbki83
14 Feb 19
Current report (foreign)
4:40pm
424B4
lomka3j
13 Feb 19
Prospectus supplement with pricing info
8:20am
F-1/A
30tyabun2ai3m2r
11 Feb 19
Registration statement (foreign) (amended)
9:52am
F-1/A
damzp1tp
8 Feb 19
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-4.1
6jp69x
8 Feb 19
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-4.1
ti3euo
5 Feb 19
Registration statement (foreign) (amended)
5:30pm
F-1/A
EX-10.3
q20b9utbkq7og7p15z
5 Feb 19
Registration statement (foreign) (amended)
5:30pm
F-1/A
EX-1.1
rddmocieuxdam0dgf53
5 Feb 19
Registration statement (foreign) (amended)
5:30pm
F-1/A
jrbb5l1boj1a7zxd
31 Jan 19
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-1.1
9ujs0s33gz2b8ap4kbuf
31 Jan 19
Registration statement (foreign) (amended)
12:00am
F-1
EX-10.5
qxk5 znkodt7b3uh
7 Jan 19
Registration statement (foreign)
5:11pm
F-1
n8qyqosn5ho38g
7 Jan 19
Registration statement (foreign)
5:11pm
DRS/A
b6d4 g4rmh8e
27 Nov 18
Draft registration statement (amended)
12:00am
DRS/A
EX-10.5
4i9k6mawb 05mmhyq9p
27 Nov 18
Draft registration statement (amended)
12:00am
DRS
nml 1uwhh08
28 Sep 18
Draft registration statement
12:00am
20-F
EX-4.15
qjhteg
23 Apr 13
Annual report (foreign)
12:00am